Get started
Author

Gunther Zischinsky

A Novel CDK7 Inhibitor of the Pyrazolotriazine Class Exerts Broad-Spectrum Antiviral Activity at Nanomolar Concentrations
2015 · Corina Hutterer, Jan Eickhoff, et al. · Antimicrobial Agents and Chemotherapy · 102
Dynarrestin, a Novel Inhibitor of Cytoplasmic Dynein
2018 · Susanne Höing, Ting-Yu Yeh, et al. · Cell chemical biology · 78
PDF
Design and Synthesis of a New Class of Selective Integrin α5β1 Antagonists
2007 · Roland Stragies, Frank Osterkamp, et al. · Journal of Medicinal Chemistry · 68
Dual Inhibition of GSK3β and CDK5 Protects the Cytoskeleton of Neurons from Neuroinflammatory-Mediated Degeneration In Vitro and In Vivo
2019 · Lydia Reinhardt, Susanne Kordes, et al. · Stem Cell Reports · 63
PDF
α5β1 Integrin Blockade Inhibits Lymphangiogenesis in Airway Inflammation
2009 · Tatsuma Okazaki, Amy Ni, et al. · American Journal Of Pathology · 51
PDF
In vivo proof-of-concept for two experimental antiviral drugs, both directed to cellular targets, using a murine cytomegalovirus model
2018 · Eric Sonntag, Friedrich Hahn, et al. · Antiviral Research · 34
Chemical Validation of DegS As a Target for the Development of Antibiotics with a Novel Mode of Action
2019 · Jens Bongard, Anna Laura Schmitz, et al. · ChemMedChem · 17
SAR of N-phenyl piperidine based oral integrin α5β1 antagonists
2009 · Gunther Zischinsky, Frank Osterkamp, et al. · Bioorganic & Medicinal Chemistry Letters · 11
Novel small molecule bradykinin B1 receptor antagonists. Part 2: 5-membered diaminoheterocycles
2009 · Gunther Zischinsky, Roland Stragies, et al. · Bioorganic & Medicinal Chemistry Letters · 10
Discovery of orally available integrin α5β1 antagonists
2009 · Gunther Zischinsky, Frank Osterkamp, et al. · Bioorganic & Medicinal Chemistry Letters · 10
Glucose metabolism controls oxidative burst and lipid mediator production in neutrophils upon microbial challenge
2025 · Alexandra Freitag, Kerstin Günther, et al. · microLife · 7
PDF
Novel small molecule bradykinin B1 receptor antagonists. Part 1: Benzamides and semicarbazides
2009 · Marco Schaudt, Elsa Locardi, et al. · Bioorganic & Medicinal Chemistry Letters · 7
Novel small molecule bradykinin B1 receptor antagonists. Part 3: Hydroxyurea derivatives
2009 · Karsten Schnatbaum, Marco Schaudt, et al. · Bioorganic & Medicinal Chemistry Letters · 6
Abstract 2997: Dynarrestin, a novel dynein inhibitor that does not block ciliogenesis
2016 · Matthias Baumann, Susanne Höing, et al. · Cancer Research · 2
Abstract 5936: A novel class of orally bioavailable small molecules induces potent and sustained tumor growth inhibition and T cell infiltration in various solid tumor mouse models
2024 · Bianca Gapp, Gunther Zischinsky, et al. · Cancer Research
Abstract 416: A novel non-covalent and rapidly reversible proteasome inhibitor for multiple myeloma and various solid cancers
2022 · Won-Gyun Ahn, Yeejin Jeon, et al. · Cancer Research
Abstract 695: The generation of a mono-selective CDK7 inhibitor.
2013 · Jan E. Eickhoff, Gunther Zischinsky, et al. · Cancer Research
Novel highly potent and selective alpha5beta1 integrin antagonists as anticancer treatments
2007 · Claudia Christner-Albrecht, Doerte Vossmeyer, et al. · Molecular Cancer Therapeutics
Linear and Cyclic Peptides for Integrin αvβ6 Inhibition
2001 · Gunther Zischinsky, Ulrich Groth, et al. · Springer eBooks
Works count: 19
Citation count: 466
H-index: 10
I10-index: 10
Year
Topic
Type